
Passion IT Framework
Pfizer Announces Positive Results With Coadministration of Prevnar 20, COVID-19 Vaccine
- ByPassionIT News --
- 2022-01-13
Pfizer has announced positive topline results from a phase 3 study evaluating the safety and immunogenicity of the company’s pneumococcal 20-valent conjugate vaccine (Prevnar 20) when coadministered with the Pfizer-BioNTech COVID-19 vaccine.
Read More at:
Related News
Purposeful innovation: How startups are solving challenges plaguing Indian healthcare
Thursday, 01 Jan, 1970
Health start-ups providing innovative solutions
Thursday, 01 Jan, 1970
Goibibo founders’ startup Eka Care raises $15 Mn in Series A
Thursday, 01 Jan, 1970
Comment